• OPEN AN ACCOUNT
Indian Indices
Sensex
84,273.92 208.17
( 0.25%)
Global Indices
Nasdaq
50,149.26 12.58
(0.03%)
Dow Jones
6,984.17 30.87
(0.44%)
Hang Seng
57,678.97 1,315.03
(2.33%)
Nikkei 225
10,354.92 -31.31
(-0.30%)
Forex
USD-INR
90.44 0.11
(0.13%)
EUR-INR
106.84 0.33
(0.31%)
GBP-INR
123.03 0.35
(0.29%)
JPY-INR
0.58 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Uniply Industries Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
532646
INE950G01023
35.5431686
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
UNIPLY
0
67.06
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

strides pharma science ltd
Fusion Finance raises Rs 800 cr via rights issue
Jan 08,2026

Fusion Finance has successfully completed the receipt of the First and Final Call money on equity shares issued under its Rights Issue, thereby marking the completion of the full payment process for the Rs 800 crore capital raise.

Under the Rights Issue, shareholders were initially allotted partly paid-up equity shares, with the issue price payable in two stages. The balance amount, designated as the First and Final Call, was fixed at Rs 65.50 per share. During the call period, the company received approximately Rs 395.30 crore, representing around 99% of the total amount called.

Following the receipt of the final payment, Fusion Finance has completed all necessary corporate actions to convert the partly paid-up shares into fully paid-up equity shares of face value Rs 10 each. These fully paid shares are available for trading on the National Stock Exchange of India (NSE) and BSE with effect from 06 January 2026.